Oncotelic Therapeutics, Inc. — Form D

Oncotelic Therapeutics, Inc. of AGOURA HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-26. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
David JJ ChaplinDirectorSouth San Francisco, CA
Roy H FicklingDirectorAtlanta, GA
Mark D KesselDirectorSouth San Francisco, CA
William N ShieblerDirectorSouth San Francisco, CA
Alastair JJ WoodDirectorSouth San Francisco, CA
David JJ ChaplinExecutive OfficerSouth San Francisco, CA
Peter J LangeckerExecutive OfficerSouth San Francisco, CA
James B MurphyExecutive OfficerWORCESTER, MA
VUONG TRIEUDirectorAGOURA HILLS, CA
VUONG TRIEUExecutive OfficerAGOURA HILLS, CA
VUONG TRIEURelated PersonAGOURA HILLS, CA
Steven KingRelated PersonAGOURA HILLS, CA
Amit ShahExecutive OfficerSAN MATEO, CA
Saran SaundExecutive OfficerAGOURA HILLS, CA
Saran SaundRelated PersonAGOURA HILLS, CA
Seymour FeinExecutive OfficerAGOURA HILLS, CA
Seymour FeinRelated PersonAGOURA HILLS, CA
Anthony MaidaExecutive OfficerRaleigh, NC
Anthony MaidaRelated PersonRaleigh, NC
William SchwietermanDirectorHouston, TX
BOBBY W SANDAGE, JR.DirectorST. LOUIS, MO
Chuho ParkExecutive OfficerAgoura Hills, CA
Fatih UckunExecutive OfficerAgoura Hills, CA
Chulho ParkExecutive OfficerAgoura Hills, CA
Matthew LoarExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2026-07-22D$712K$712K
2025-12-11D$12.5M$275K
2023-07-13D$5.0M
2020-08-04D$5.0M$2.0M
2019-05-07D$1.2M$600K
2019-05-07D$27.0M$27.0M
2018-04-25D$12.0M$2.9M

More